New Inpatient Visitor Check-In Process Effective March 10. Learn more here.
Fox Chase Cancer Center Welcomes Dr. Michael Noonan
PHILADELPHIA (February 13, 2025) — Fox Chase Cancer Center is pleased to announce the hiring of Michael Noonan, DO, MS, as an Assistant Professor in the Supportive Oncology and Palliative Care Program.
Noonan joins Fox Chase from Christiana Care Health System, where he served as a supportive and palliative care physician. In this role, he provided comprehensive palliative medicine services across various inpatient medical and surgical services.
The Supportive Oncology and Palliative Care Program at Fox Chase provides for patients and their families, with a focus on reducing the patient’s pain and other distressing symptoms. The program is dedicated to addressing physical, emotional, and spiritual needs while being mindful of patient and family values.
Noonan received his Doctor of Osteopathic Medicine degree from the University of Medicine and Dentistry of New Jersey and then completed an osteopathic rotating internship at Graduate Hospital. He also completed a family medicine residency at Boston University Medical Center and an addiction medicine fellowship at Thomas Jefferson University Hospital. He is board certified in hospice and palliative medicine.
From 2009 through 2021, Noonan worked as a primary care physician and hospitalist in Colorado and California. Throughout his career, Noonan has made significant contributions to palliative care and addiction medicine. His experience includes palliative care for individuals suffering from addiction, health advocacy for underserved populations, and the use of statistical modeling to improve care outcomes. He is also deeply committed to advancing mental health initiatives within palliative and addiction medicine.
He holds board certifications in family medicine and addiction medicine and has been involved in several professional organizations, including the Health First Colorado Drug Utilization Review Board, where he served as board member and board chairperson.
Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.
For more information, call 888-369-2427